These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31271354)

  • 21. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis.
    Kang YA; Kim SY; Jo KW; Kim HJ; Park SK; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Kim DY; Shim TS
    Respiration; 2013; 86(6):472-8. PubMed ID: 23689646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effectiveness of Tuberculosis Treatment Daily versus Intermittent Regimen in Indonesian TB-DM Patients: Real World Patient Database Study.
    Siane A; Ascobat P; Instiaty I; Agustin H
    Acta Med Indones; 2020 Jan; 52(1):25-30. PubMed ID: 32291368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis associated with diabetes mellitus by age group in Brazil: a retrospective cohort study, 2007-2014.
    Evangelista MDSN; Maia R; Toledo JP; Abreu RG; Barreira D
    Braz J Infect Dis; 2020; 24(2):130-136. PubMed ID: 32298639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction.
    Queiroz ATL; Vinhaes CL; Fukutani ER; Gupte AN; Kumar NP; Fukutani KF; Arriaga MB; Sterling TR; Babu S; Gaikwad S; Karyakarte R; Mave V; Paradhkar M; Viswanathan V; Gupta A; Andrade BB; Kornfeld H; ;
    Sci Rep; 2023 May; 13(1):7769. PubMed ID: 37173394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological recovery in patients with pulmonary tuberculosis after intensive phase treatment.
    Luo X; Wu F; Ma J; Xiao H; Cui H
    J Int Med Res; 2018 Sep; 46(9):3539-3551. PubMed ID: 29756540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania.
    Nagu TJ; Spiegelman D; Hertzmark E; Aboud S; Makani J; Matee MI; Fawzi W; Mugusi F
    PLoS One; 2014; 9(3):e91229. PubMed ID: 24642636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
    Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
    Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between pulmonary tuberculosis and Type 2 diabetes in Sudanese patients.
    Ahmed M; Omer I; Osman SM; Ahmed-Abakur EH
    Int J Mycobacteriol; 2017; 6(1):97-101. PubMed ID: 28317813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment.
    Kornfeld H; Procter-Gray E; Kumpatla S; Kane K; Li W; Magee MJ; Babu S; Viswanathan V
    Diabetes Res Clin Pract; 2023 Feb; 196():110242. PubMed ID: 36627027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
    Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis.
    Chiang CY; Bai KJ; Lin HH; Chien ST; Lee JJ; Enarson DA; Lee TI; Yu MC
    PLoS One; 2015; 10(3):e0121698. PubMed ID: 25822974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring treatment responses in patients with pulmonary TB using serial lung gallium-67 scintigraphy.
    Liu SF; Liu JW; Lin MC; Lee CH; Huang HH; Lai YF
    AJR Am J Roentgenol; 2007 May; 188(5):W403-8. PubMed ID: 17449733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis screening among persons with diabetes mellitus in Pune, India.
    Mave V; Nimkar S; Prasad H; Kadam D; Meshram S; Lokhande R; Gupte N; Jain D; Gupta A; Golub JE
    BMC Infect Dis; 2017 Jun; 17(1):388. PubMed ID: 28577535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
    Muñoz-Torrico M; Caminero-Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Vergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Arch Bronconeumol; 2017 May; 53(5):245-250. PubMed ID: 28089216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review.
    Workneh MH; Bjune GA; Yimer SA
    PLoS One; 2017; 12(4):e0175925. PubMed ID: 28430796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender biased immune-biomarkers in active tuberculosis and correlation of their profiles to efficacy of therapy.
    Chavez K; Ravindran R; Dehnad A; Khan IH
    Tuberculosis (Edinb); 2016 Jul; 99():17-24. PubMed ID: 27450000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.
    Gupte AN; Mave V; Meshram S; Lokhande R; Kadam D; Dharmshale S; Bharadwaj R; Kagal A; Pradhan N; Deshmukh S; Atre S; Sahasrabudhe T; Barthwal M; Meshram S; Kakrani A; Kulkarni V; Raskar S; Suryavanshi N; Shivakoti R; Chon S; Selvin E; Gupte N; Gupta A; Golub JE
    Int J Tuberc Lung Dis; 2018 Jul; 22(7):800-806. PubMed ID: 30041729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study.
    Carvalho ACC; Amorim G; Melo MGM; Silveira AKA; Vargas PHL; Moreira ASR; Rocha MS; Souza AB; Arriaga MB; Araújo-Pereira M; Figueiredo MC; Durovni B; Lapa-E-Silva JR; Cavalcante S; Rolla VC; Sterling TR; Cordeiro-Santos M; Andrade BB; Silva EC; Kritski AL;
    Front Immunol; 2021; 12():661934. PubMed ID: 34276654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.
    Kumar NP; Banurekha VV; Nair D; Kumaran P; Dolla CK; Babu S
    Tuberculosis (Edinb); 2015 Dec; 95(6):707-712. PubMed ID: 26354610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.